RGC Regencell Bioscience
- 5.330
- -1.160-17.87%
Regencell Bioscience News
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. Nexalin Technology (NASD
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAptorum Gr (NASDAQ:APM) stock moved upwards by 780.6% to $12.77 during Wednesday's regular session. The company's market cap stands at $66.1 million. NKGen Biotech (NASDAQ:NKGN) stock rose 302.
Regencell Bioscience Holdings Limited (NASDAQ:RGC) CEO Yat-Gai Au's Holdings Dropped 16% in Value as a Result of the Recent Pullback
Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersFulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday's regular session. Fulcrum Therapeutics's stock is trading at a volume of 68.5 million shares as of 13:31 EST. This i
With 81% Ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) Insiders Have a Lot Riding on the Company's Future
Relevant Gold Corp Brief: Closed Oversubscribed $3 Million Non-Brokered Private Placement With Participation From New Gold and Rob McEwen
05:31 PM EDT, 06/08/2023 (MT Newswires) -- Relevant Gold Corp Brief: Closed Oversubscribed $3 Million Non-Brokered Private Placement with Participation from New Gold and Rob McEwen
Reversal Of Fortune For Regencell Bioscience Holdings Insiders Who Made A US$886k Purchase \
Insiders who bought US$886k worth of Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock in the last year have seen some of their losses recouped as the stock gained 25% last week. However, the
Regencell Bioscience Up Over 22%, on Pace for Largest Percent Increase Since November 2021 -- Data Talk
Regencell Bioscience Holdings Ltd. (RGC) is currently at $27.50, up $5.00 or 22.22% --Would be highest close since April 19, 2023, when it closed at $28.25 --On pace for largest percent increase sin
12 Health Care Stocks Moving In Monday's Intraday Session
GainersINVO Bioscience (NASDAQ:INVO) stock rose 50.9% to $0.32 during Monday's regular session. Trading volume for this security as of 13:30 EST is 5.4 million, which is 2816.2% of its average full-da
Yat-Gai Au Regencell Bioscience Holdings Limited's (NASDAQ:RGC) CEO Is the Most Bullish Insider, and Their Stock Value Gained 15%last Week
To get a sense of who is truly in control of Regencell Bioscience Holdings Limited (NASDAQ:RGC), it is important to understand the ownership structure of the business. And the group that holds the bi
Flowers Foods, EverCommerce, And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded mixed, with the Nasdaq gaining more than 100 points on Friday. Here are some big stocks recording losses in today's session. Expensify, Inc. (NASDAQ:EXFY) dropped 19.2% to $10.46 af
Domino's Pizza, Athersys And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping around 400 points on Friday. Here are some big stocks recording gains in today's session. Athersys, Inc. (NASDAQ:ATHX) shares jumped 43% to $1.67
81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) Is Owned by Insiders, and They've Been Buying Recently
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of Its Second Efficacy Trial
- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD ("SKATBT-A3"), which measures the effectiveness of the treatment on the patient's overall body and neurodevelopmental conditions, showed
Bullish Regencell Bioscience Holdings Limited (NASDAQ:RGC) Insiders Were Rewarded Last Week as Their US$6.0m Investment Inflated to US$7.1m
Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 20%, resulting in a US$69m rise in the company's mar
What Type Of Shareholders Own The Most Number of Regencell Bioscience Holdings Limited (NASDAQ:RGC) Shares?
Every investor in Regencell Bioscience Holdings Limited (NASDAQ:RGC) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while hug
RGC: CEO Figuratively Putting His Money Where His Mouth Is
By Beth Senko, CFANASDAQ:RGCInvestors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising inte
Analysis
Price Target
No Data
